Not yet recruiting

NCT Number: NCT07773181

Nurse Led Aromatherapy

The goal of this trial is to see if aromatherapy in addition to pain medication, will help manage pain in pediatric burn patients during their first burn dressing change. Participants aged 2 months to 7 years old will be randomly assigned to usual care (pain medication only) or to receive aromatherapy in addition to pain medication prior to their first burn dressing change. The main question it aims to answer is:

-Does aromatherapy plus pain medication decrease pain more than pain medication alone for young children receiving their first burn dressing change?

All participants will receive the standard pain medications and have their pain assessed on medication administration (prior to aromatherapy for the intervention group), prior to dressing change (after aromatherapy for the intervention group), and 15 minutes after the dressing change is complete.

Once the final pain assessment is complete, there is no more information needed from participants for the purposes of the study. All participants will continue to follow up in the clinic for the remaining dressing changes as needed.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Burns and Scalds Burns Wounds and Injuries

Age range

2 month–7 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

KK Women and Children's Hospital

Singapore

Location contact

Eugenie SpiguelPh, PhD

PRINCIPAL_INVESTIGATOR

Teo Agnes, Research Coordinator

CONTACT

[email protected]

+65 6225 5554

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Seen in outpatient burn center
Burns not covering more than 7.5% of body surface area
First burn dressing change
Second degree burns
Scalding, flame, or contact burns

Exclusion criteria

Allergy/hypersensitivity to essential oils, or any components of the aromatherapy formula
Airway/hypersensitivity to fragrances, paint fumes, or turpentine
Respiratory conditions (e.g. asthma, reactive airway disease, recent wheezing)
Inhalation injury

Thermal injury: Caused by direct thermal damage which affects upper airways resulting in edema, stridor and upper airway obstruction
Chemical injury to airways and lung parenchyma from products of combustion
Systemic poisoning from carbon monoxide and/or cyanide
Surgery for burn
Infection of burn
Burns of the face
Burns requiring Acticoat dressing
Delayed burns (those that have been previously treated outside of the hospital, but have not healed and require further treatment)

Treatment and study plan

Aromatherapy

Other

Aromatherapy diffusion is a blend of three essential oils, bergamot mint, patchouli, and sweet orange.

Primary outcomes

Pain score as measured by Face, Legs, Activity, Cry, and Consolability (FLACC) scale with first burn dressing change

Time frame: FLACC to be completed upon arrival in burn center (baseline), immediately prior to burn dressing change (preprocedural), and 15 minutes after burn dressing change is complete (postprocedural).

Zero is equivalent to no pain and 10 indicates severe pain

Study contacts

Contact information is provided by the study sponsor or research team.

Eugenie Spiguel, PhD

CONTACT

[email protected]

+65 6225 5554

Joanne Cheng, DNP

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

KK Women's and Children's Hospital

Other Gov

Collaborators

National Cancer Centre, Singapore

Registry information

Important dates

Study start: 2026
Primary completion: 2028
Study completion: 2028
First posted: Aug 19, 2026
Registry last updated: Aug 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed